This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1991 Sep 11;266(10):1357-8.

Estrogen replacement therapy and risk of breast cancer

T L Bush, K Helzlsouer

PMID: 1880860

Comment

Estrogen replacement therapy and risk of breast cancer

T L Bush et al. JAMA. 1991.

. 1991 Sep 11;266(10):1357-8.

Authors

T L Bush, K Helzlsouer

PMID: 1880860

No abstract available

PubMed Disclaimer

Comment on

Estrogen replacement therapy and risk of breast cancer.
[No authors listed] [No authors listed] JAMA. 1991 Apr 10;265(14):1824-5. JAMA. 1991. PMID: 2005728 No abstract available.

Similar articles

[Estrogen replacement therapy and breast cancer].
Fisher M. Fisher M. Harefuah. 1994 Dec 15;127(12):538-41. Harefuah. 1994. PMID: 7813933 Review. Hebrew. No abstract available.
Estrogen replacement therapy and breast cancer.
Maguire PJ. Maguire PJ. J Reprod Med. 1993 Mar;38(3):183-5. J Reprod Med. 1993. PMID: 8487233 Review.
Relative versus attributable risk of breast cancer from estrogen replacement therapy.
Santen RJ, Petroni GR. Santen RJ, et al. J Clin Endocrinol Metab. 1999 Jun;84(6):1875-81. doi: 10.1210/jcem.84.6.5771. J Clin Endocrinol Metab. 1999. PMID: 10372679 Review. No abstract available.
Breast cancer and hormone-replacement therapy.
Brunoski T. Brunoski T. N Engl J Med. 1995 Nov 16;333(20):1355; author reply 1357-8. doi: 10.1056/NEJM199511163332013. N Engl J Med. 1995. PMID: 7566032 No abstract available.
Estrogen and breast cancer risk.
[No authors listed] [No authors listed] Harv Womens Health Watch. 1999 Aug;6(12):1. Harv Womens Health Watch. 1999. PMID: 10402322 No abstract available.

See all similar articles

Cited by

Postmenopausal hormone replacement: are two hormones better than one?
Wood H, Wang-Cheng R, Nattinger AB. Wood H, et al. J Gen Intern Med. 1993 Aug;8(8):451-8. doi: 10.1007/BF02599627. J Gen Intern Med. 1993. PMID: 8410413 Review. No abstract available.
Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.
Ma B, Zhang Q, Wu D, Wang YL, Hu YY, Cheng YP, Yang ZD, Zheng YY, Ying HJ. Ma B, et al. Acta Pharmacol Sin. 2012 Apr;33(4):479-89. doi: 10.1038/aps.2011.177. Epub 2012 Mar 19. Acta Pharmacol Sin. 2012. PMID: 22426695 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information